Navigation Links
OncoMed Pharmaceuticals Announces FDA Clearance to Commence Phase 1 Testing of Anti-Cancer Stem Cell Therapeutic OMP-18R5
Date:4/28/2011

ling pathway.  Bayer has the option to license OncoMed's biologics in the Wnt pathway at any point through the completion of Phase 1 studies.  In addition, Bayer and OncoMed are working together to discover small molecule Wnt signaling inhibitors as part of the collaboration.

About Cancer Stem Cells

Cancer stem cells, a small, resilient subset of cells found in tumors, have the capacity to self-renew and differentiate, leading to tumor initiation and driving tumor growth, recurrence and metastasis.  Also referred to as "tumor-initiating cells," these cells were first discovered by OncoMed's scientific founders in breast cancer and have subsequently been identified in many other types of solid tumor cancers, including cancer of head and neck, lung, prostate, pancreas and glioblastoma.  Cancer stem cells appear to be preferentially resistant to both standard chemotherapy and radiotherapy.  OncoMed's strategy is to improve cancer treatment by specifically targeting the key biologic pathways which are thought to be critical to the activity and survival of cancer stem cells.  OncoMed's novel therapeutics target cancer stem cell proteins and have the potential to be developed against a range of tumor types.  

About OncoMed Pharmaceuticals

OncoMed Pharmaceuticals is a clinical-stage company that discovers and develops novel therapeutics targeting cancer stem cells, the cells believed to be capable of driving tumor growth, recurrence and metastasis.  A leader in cancer stem cell research, the company has established a library of antibodies to cancer stem cell proteins for the treatment of solid tumors such as pancreatic, breast, colorectal and lung cancers.  OncoMed has advanced three anti-cancer stem cell monoclonal antibodies into the clinic, OMP-21M18, OMP-59R5 and OMP-18R5, which target key cancer stem cell signaling pathways including Notch and Wnt.  In addition, OncoMed's pipe
'/>"/>

SOURCE OncoMed Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. OncoMed Chooses SynCo Bio Partners to Fill and Finish its Lead Antibody
2. SynCo Expands Agreement with OncoMed Pharmaceuticals to Manufacture Cancer Stem Cell Antibodies
3. Bayer and OncoMed Pharmaceuticals Enter Strategic Alliance to Develop Anti-Cancer Stem Cell Therapeutics
4. OncoMed Pharmaceuticals Awarded Five Therapeutic Discovery Project Grants Totaling $1.2 Million
5. OncoMed Pharmaceuticals Initiates Phase 1 Clinical Trial of Anti-Cancer Stem Cell Therapeutic OMP-59R5
6. OncoMed Anti-Cancer Stem Cell Antibody OMP-21M18 Demonstrates Potent Activity in Preclinical Studies Against Human Colon Cancer Tumors Regardless of KRAS Mutation Status
7. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
8. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
9. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
10. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
11. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... WASHINGTON , July 23, 2014  Nearly 8,000 ... for Cardinal Health,s annual Retail Business Conference (RBC), ... & Convention Center. This year,s event encourages pharmacists to ... in their communities and for their future. ... pharmacy owners to network with their peers and learn ...
(Date:7/23/2014)... July 23, 2014  The management team at ... will hold a conference call on July 31, ... quarter ended June 30, 2014.  The call details ... , 8:30 am EDTDial-in numbers: , Toll free: ... 317-0790Webcast (live & archive): , www.columbialabs.com , ...
(Date:7/23/2014)... , July 23, 2014 This September ... in Las Vegas for ... by educator, author, forward thinker and private practitioner Dr. ... experts together to candidly discuss clinical and practice management ... event is a unique opportunity to welcome fresh thinking ...
Breaking Medicine Technology:Cardinal Health Encourages Independent Pharmacists to Lead Change at 24th Annual Retail Business Conference 2Cardinal Health Encourages Independent Pharmacists to Lead Change at 24th Annual Retail Business Conference 3Cardinal Health Encourages Independent Pharmacists to Lead Change at 24th Annual Retail Business Conference 4Cardinal Health Encourages Independent Pharmacists to Lead Change at 24th Annual Retail Business Conference 5Cardinal Health Encourages Independent Pharmacists to Lead Change at 24th Annual Retail Business Conference 6Columbia Laboratories to Discuss Second Quarter 2014 Financial Results on July 31st Conference Call 22014 DOCtalk Registration Now Open 22014 DOCtalk Registration Now Open 3
... Luminex Corporation (NASDAQ: LMNX ) today announced ... Inc., an innovator in molecular diagnostic testing technologies for ... cash. (Logo:   http://photos.prnewswire.com/prnh/20100104/LUMINEXLOGO ) ... million and $7 million to 2011 consolidated revenue. On ...
... Providers of durable medical equipment and services (DME) required in ... controversial "competitive" bidding for homecare, which cuts quality and access ... The program is opposed by the American Association ... such as the ALS Association and the ...
Cached Medicine Technology:Luminex Corporation Completes Acquisition of EraGen Biosciences, Inc. 2Luminex Corporation Completes Acquisition of EraGen Biosciences, Inc. 3At-Home Care Businesses Urge President Obama to Repeal Medicare Program that Cuts Access to Homecare 2At-Home Care Businesses Urge President Obama to Repeal Medicare Program that Cuts Access to Homecare 3At-Home Care Businesses Urge President Obama to Repeal Medicare Program that Cuts Access to Homecare 4
(Date:7/23/2014)... The European Vitamins Market report explains and divides ... of revenue. The market in Europe is estimated to ... million by 2018, at a CAGR of 6.8% from ... the European Vitamins Market report, to get an idea ... glimpse of the segmentation in the European market, and ...
(Date:7/23/2014)... European Bio fertilizers Market Report defines and segments the ... of revenue. The bio fertilizers market in Europe is ... 2012 to $4,582.2 million by 2017, at a CAGR ... the TOC of the European Bio fertilizers Market report, ... , http://www.micromarketmonitor.com/market/europe-bio-fertilizer-4637178345.html , The bio fertilizers ...
(Date:7/23/2014)... Bethesda, MD (July 23, 2014) Statins, a class ... reduce a patient,s risk of developing Barrett,s esophagus, according ... , the official journal of the American ... risk reduction with statin use. , "Patients who received ... of having Barrett,s esophagus compared to non-users," said study ...
(Date:7/23/2014)... According to a new market research report of "Semiconductor ... SOC IP), Design Architecture (Hard IP, Soft IP), Processor ... Forecast & Analysis to 2013 - 2020", the semiconductor ... CAGR of 12.6% from 2014 to 2020 and reach ... market data tables with 60 figures spread through 337 ...
(Date:7/23/2014)... new study in East Asian women has identified three ... cancer. The research, led by Vanderbilt University investigators, was ... , While breast cancer is one of the most ... genetic risk factors for the disease have focused on ... genetic heritage and environmental exposures between East Asian women ...
Breaking Medicine News(10 mins):Health News:Europe Vitamins (Nutraceuticals) Market is Expected to Reach $1,202.08 Million in 2018 - New Report by MicroMarket Monitor 2Health News:Europe Vitamins (Nutraceuticals) Market is Expected to Reach $1,202.08 Million in 2018 - New Report by MicroMarket Monitor 3Health News:Europe Vitamins (Nutraceuticals) Market is Expected to Reach $1,202.08 Million in 2018 - New Report by MicroMarket Monitor 4Health News:Europe Vitamins (Nutraceuticals) Market is Expected to Reach $1,202.08 Million in 2018 - New Report by MicroMarket Monitor 5Health News:Europe Bio Fertilizer Market is Expected to Reach $4,582.2 Million in 2017 - New Report by MicroMarket Monitor 2Health News:Europe Bio Fertilizer Market is Expected to Reach $4,582.2 Million in 2017 - New Report by MicroMarket Monitor 3Health News:Europe Bio Fertilizer Market is Expected to Reach $4,582.2 Million in 2017 - New Report by MicroMarket Monitor 4Health News:Statin use decreases the risk of Barrett's esophagus 2Health News:Semiconductor IP Market Estimated to Reach $5.63 Billion by 2020 – New Report by MarketsandMarkets 2Health News:Semiconductor IP Market Estimated to Reach $5.63 Billion by 2020 – New Report by MarketsandMarkets 3Health News:Semiconductor IP Market Estimated to Reach $5.63 Billion by 2020 – New Report by MarketsandMarkets 4Health News:Semiconductor IP Market Estimated to Reach $5.63 Billion by 2020 – New Report by MarketsandMarkets 5Health News:Semiconductor IP Market Estimated to Reach $5.63 Billion by 2020 – New Report by MarketsandMarkets 6Health News:Vanderbilt-led study identifies genes linked to breast cancer in East Asian women 2
... produced audio or video for a internet directory or their ... Jeff Fisher, the developer of CounsellingBC.com ... word can provide when selecting a therapist from one of ... It,s a new phenomenon that is bound to gain ...
... The Minnesota Chiropractic Association (MCA) recently honored twelve (12) doctors for ... Madden,s in Brainerd, recognized those among them who have consistently supported ... health. Those honored were:, , ... Dr. Douglas Edwards, Albert Lea, MN ...
... and Honorary Chair Kristin Davis of acclaimed show Sex ... Hospital on Thursday, May 28th 2009, 8:00pm at Capitale to ... au Vin Affair, . It,s a first for New York ... with a musical performance by the legendary Tony Bennett, gourmet ...
... Weigh in on Kidz-Med ThermofocusWESTON, Fla., May 22 ... (Pink Sheets: ASFX) is excited to see that awareness ... is increasing surrounding taking a child,s temperature with the ... daytime talk show The Doctors , renowned pediatrician ...
... (Nasdaq: CRDC ) today announced that, on ... Listing Qualifications Department of The NASDAQ Global Market (NASDAQ) ... $10 million stockholders, equity requirement for continued listing on ... Rule 5450(b)(1)(A) (the "Minimum Equity Requirement"). As provided by ...
... goals is what leads to well-being , , FRIDAY, May 22 ... fame may sound like a sure ticket to happiness, but ... of Rochester in New York tracked 147 college graduates, evaluating ... -- one year after graduation, and then 12 months later. ...
Cached Medicine News:Health News:What's in a Video or a Sound Bite When You're Looking for a Therapist? 2Health News:What's in a Video or a Sound Bite When You're Looking for a Therapist? 3Health News:Celebrities to Highlight at St. Jude's Inaugural Wine and Chocolate Gala 2Health News:Awareness Increases on New Health and Safety Technology for Kids 2Health News:Awareness Increases on New Health and Safety Technology for Kids 3Health News:Cardica Receives NASDAQ Notification 2Health News:Looks, Money, Fame Don't Bring Happiness 2
... and T-CAT have been optimized to complete ... and to interact in perfect synchronization with ... necessary treatment and patient parameters are transferred ... WAVE laser systems via diskette, mini CD ...
... ALLEGRO Analyzer has been specifically ... needed to perform safe and ... correction. All components such as ... algorithms have been optimized to ...
... & Lomb's Orbscan IIz is a fully ... beyond mere topography. Unlike current topography systems ... at standard points, the Orbscan II acquires ... to meticulously map the entire corneal surface ...
... Absolute precision demands absolute ... Bausch & Lomb Zyoptix Diagnostic ... Zywave II Wavefront Aberrometer and ... System. Individually they supply critically ...
Medicine Products: